Preclinical • Journal
|
KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • SMAD4 (SMAD family member 4) • KMT2C (Lysine Methyltransferase 2C) • APC (APC Regulator Of WNT Signaling Pathway) • CDKN1B (Cyclin dependent kinase inhibitor 1B) • CA 19-9 (Cancer antigen 19-9)
|
TP53 mutation • KRAS mutation • PIK3CA mutation • TP53 wild-type • APC mutation • SMAD4 mutation
|
5-fluorouracil • Lumakras (sotorasib) • oxaliplatin